560 related articles for article (PubMed ID: 22149139)
1. Enhancement of the targeting capabilities of the Paclitaxel-loaded pluronic nanoparticles with a glycol chitosan/heparin composite.
Yuk SH; Oh KS; Cho SH; Kim SY; Oh S; Lee JH; Kim K; Kwon IC
Mol Pharm; 2012 Feb; 9(2):230-6. PubMed ID: 22149139
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel-loaded Pluronic nanoparticles formed by a temperature-induced phase transition for cancer therapy.
Oh KS; Song JY; Cho SH; Lee BS; Kim SY; Kim K; Jeon H; Kwon IC; Yuk SH
J Control Release; 2010 Dec; 148(3):344-50. PubMed ID: 20797418
[TBL] [Abstract][Full Text] [Related]
3. Blood-pool multifunctional nanoparticles formed by temperature-induced phase transition for cancer-targeting therapy and molecular imaging.
Oh KS; Lee S; Na JH; Kim JY; Kim DE; Kim K; Kwon IC; Yuk SH; Jeong SY
Int J Pharm; 2012 Nov; 437(1-2):192-202. PubMed ID: 22944301
[TBL] [Abstract][Full Text] [Related]
4. PEG conjugated N-octyl-O-sulfate chitosan micelles for delivery of paclitaxel: in vitro characterization and in vivo evaluation.
Qu G; Yao Z; Zhang C; Wu X; Ping Q
Eur J Pharm Sci; 2009 May; 37(2):98-105. PubMed ID: 19429416
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic((R))P85, an in vitro cell line and in vivo biodistribution studies on rat model.
Shah N; Chaudhari K; Dantuluri P; Murthy RS; Das S
J Drug Target; 2009 Aug; 17(7):533-42. PubMed ID: 19530913
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of paclitaxel-loaded DSPE-PEG-liquid crystalline nanoparticles (LCNPs) for improved bioavailability.
Zeng N; Hu Q; Liu Z; Gao X; Hu R; Song Q; Gu G; Xia H; Yao L; Pang Z; Jiang X; Chen J; Fang L
Int J Pharm; 2012 Mar; 424(1-2):58-66. PubMed ID: 22240390
[TBL] [Abstract][Full Text] [Related]
7. Hydrotropic oligomer-conjugated glycol chitosan as a carrier of paclitaxel: synthesis, characterization, and in vivo biodistribution.
Saravanakumar G; Min KH; Min DS; Kim AY; Lee CM; Cho YW; Lee SC; Kim K; Jeong SY; Park K; Park JH; Kwon IC
J Control Release; 2009 Dec; 140(3):210-7. PubMed ID: 19560497
[TBL] [Abstract][Full Text] [Related]
8. Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery.
Song N; Liu W; Tu Q; Liu R; Zhang Y; Wang J
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):454-63. PubMed ID: 21719259
[TBL] [Abstract][Full Text] [Related]
9. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells.
Nag M; Gajbhiye V; Kesharwani P; Jain NK
Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697
[TBL] [Abstract][Full Text] [Related]
10. PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation.
Jiang X; Xin H; Sha X; Gu J; Jiang Y; Law K; Chen Y; Chen L; Wang X; Fang X
Int J Pharm; 2011 Nov; 420(2):385-94. PubMed ID: 21920419
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
[TBL] [Abstract][Full Text] [Related]
12. Glycol chitosan/heparin immobilized iron oxide nanoparticles with a tumor-targeting characteristic for magnetic resonance imaging.
Yuk SH; Oh KS; Cho SH; Lee BS; Kim SY; Kwak BK; Kim K; Kwon IC
Biomacromolecules; 2011 Jun; 12(6):2335-43. PubMed ID: 21506550
[TBL] [Abstract][Full Text] [Related]
13. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
[TBL] [Abstract][Full Text] [Related]
14. The multilayer nanoparticles formed by layer by layer approach for cancer-targeting therapy.
Oh KS; Lee H; Kim JY; Koo EJ; Lee EH; Park JH; Kim SY; Kim K; Kwon IC; Yuk SH
J Control Release; 2013 Jan; 165(1):9-15. PubMed ID: 23103984
[TBL] [Abstract][Full Text] [Related]
15. Multi-core vesicle nanoparticles based on vesicle fusion for delivery of chemotherapic drugs.
Yuk SH; Oh KS; Koo H; Jeon H; Kim K; Kwon IC
Biomaterials; 2011 Nov; 32(31):7924-31. PubMed ID: 21784512
[TBL] [Abstract][Full Text] [Related]
16. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.
Xin H; Chen L; Gu J; Ren X; Wei Z; Luo J; Chen Y; Jiang X; Sha X; Fang X
Int J Pharm; 2010 Dec; 402(1-2):238-47. PubMed ID: 20934500
[TBL] [Abstract][Full Text] [Related]
17. Selective tissue distribution and long circulation endowed by paclitaxel loaded PEGylated poly(ε-caprolactone-co-L-lactide) micelles leading to improved anti-tumor effects and low systematic toxicity.
Wang F; Shen Y; Xu X; Lv L; Li Y; Liu J; Li M; Guo A; Guo S; Jin F
Int J Pharm; 2013 Nov; 456(1):101-12. PubMed ID: 23968782
[TBL] [Abstract][Full Text] [Related]
18. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
[TBL] [Abstract][Full Text] [Related]
19. [Preparation of paclitaxel-loaded chitosan polymeric micelles and influence of surface charges on their tissue biodistribution in mice].
Huo MR; Zhou JP; Wei Y; Lü L
Yao Xue Xue Bao; 2006 Sep; 41(9):867-72. PubMed ID: 17111835
[TBL] [Abstract][Full Text] [Related]
20. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting.
Chung YI; Kim JC; Kim YH; Tae G; Lee SY; Kim K; Kwon IC
J Control Release; 2010 May; 143(3):374-82. PubMed ID: 20109508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
